VR MED

VR MED is the first medical device in the world to use VR technology for a variety of uses. Not only in ophthalmology, but also in neurology and rehabilitation. This device contains most of the clinical needs with VR technology. Currently, VR headphones can replace 40% of all eye devices at a cost of less than six times the Gold Standard cost. The development of a new approach to patient diagnosis and treatment is ongoing. Patented technology. The VRMD card will be the platform's internal currency and allow users to acquire software to expand device functionality and support new platform development.

VR MED software and hardware for screening in the field of ophthalmology were tested at the Russian Academy of Sciences Institute of Ophthalmology and Fah Aachen University of Applied Sciences, Germany. Today, VR helmets can replace 40% of all specialist eye specialist clinics for less than six times the cost of the "Gold Standard" device.

The VR MED headset provides visual field analysis for doctors to diagnose early stage glaucoma. Fah Aachen completed his initial hearing test at the University of Applied Sciences, confirming the uniqueness and innovation of this product. Now the device is being tested at the Institute of Russian Academy of Eye Sciences.

VR MED is integrated into ergonomic headphones, which, unlike the jury, offer greater sensitivity at fast palette speeds. This allows the ear to be used in a variety of medical settings.

VRMD is a local currency platform that allows Token owners.Get the product and use a lower rate than the correct service price currency.Access software updates, improve your ear function, and buy andselling data. Create resources for new medical development for VR MED headphones. Increased demand forstreams will depend on demand growth for equipment and upgrades.

Blockchain is the basis for a standard. VRMD-tokens are internal payment instruments that will provide interaction between participants. Smart contracts automate payments between clinic and developer. In addition, this will allow investor-investor relations, including financial requirements, to be changed as well as conditions for the distribution of profits and profits from those funds. For this reason, the VR MED barrier platform eliminates unnecessary intermediaries and forms the necessary infrastructure to maximize the effectiveness of ecosystem developm